Keyphrases
Spatial Landscape
95%
Entinostat
95%
Tumor Microenvironment
77%
Pancreatic Ductal Adenocarcinoma
74%
Myeloid Cells
73%
Tumor
63%
Lymph Node
59%
Anti-tumor Response
57%
Molecular Interactions
47%
Latent Space
47%
Reverse Antibiotic
47%
Breast Tumor Microenvironment
47%
Cell Systems
47%
HER2+
47%
Immune Suppression
47%
Accession number
47%
Systems Immunology
47%
Metastatic Pancreatic Ductal Adenocarcinoma
47%
Phosphodiesterase Type 5 Inhibitors
47%
Tertiary Lymphoid Structures
47%
Nivolumab
47%
Phase II Clinical Trial
47%
Tadalafil
47%
Apologizing
23%
Systemic Interaction
23%
Leukocyte Trafficking
23%
Adaptive Immunity
23%
Immune Cells
23%
Regret
23%
Immune System
23%
Therapeutic Response
23%
Disease Progression
23%
Last Digits
23%
Immunomics
23%
Systems-based Approach
23%
Cancer Progression
23%
Computational Methods
23%
Lymphocytes
23%
Chemotherapy Resistance
23%
Complex Networks
23%
Tumor Cells
23%
Cancer Cells
23%
Local Interaction
23%
Lymphocyte Dynamics
23%
Mesothelin
19%
Antitumor Efficacy
19%
Tumor Immune Microenvironment
19%
Immunosuppressive Myeloid Cells
19%
T Cell Activation
19%
T Cells
15%
Immunology and Microbiology
Mouse
100%
Immunotherapy
95%
Myeloid
95%
T Cell
80%
Immunosuppressive Drug
74%
Cancer Cell
71%
Transfer of Learning
59%
Lymph Node
59%
Microbiome
55%
Feces microflora
47%
Immunology
47%
Microflora
47%
Molecular Interaction
47%
Myeloid-Derived Suppressor Cell
47%
Germfree Mouse
47%
Lymphocyte
47%
Cancer Associated Fibroblast
47%
Maturation
47%
Tertiary Lymphoid Structure
47%
RNA Sequence
37%
Dynamics
35%
Immunocompetent Cell
35%
Immunity
34%
Tumor Cell
30%
Mass Cytometry
30%
Adaptive Immune System
29%
Coculture
27%
Intestine Flora
26%
Tumor-Associated Macrophage
23%
Immune System
23%
Immunosuppression
23%
Immunomics
23%
Sensitization
23%
Leukocyte
23%
STAT3
23%
Organoid
20%
Clostridium
17%
Mesothelin
13%
Cancer Immunotherapy
11%
Patient Coding
11%
RNA Gene
9%
Gut Microbiome
9%
Microbial Diversity
9%
Taxon
9%
Amplicon Sequencing
9%
Microorganism
9%
Bacteroides
9%
Akkermansia
9%
Transplant Procedure
9%
Lactobacillus
9%
Medicine and Dentistry
Tumor Microenvironment
95%
Entinostat
95%
Pancreas Adenocarcinoma
95%
Myeloid Cell
73%
Neoplasm
70%
Immunotherapy
59%
Immunosuppressive Treatment
54%
Transcriptomics
47%
Breast Tumor
47%
Nivolumab
47%
Clinical Trial
47%
Phosphodiesterase V
47%
Tadalafil
47%
Immunity
42%
Immunosuppressive Drug
40%
T Cell
38%
Cell Interaction
23%
Immune Checkpoint Inhibitor
19%
Tumor Immune Microenvironment
19%
Mesothelin
19%
Cell Activation
16%
RNA Sequence
15%
Progression Free Survival
13%
Overall Survival
13%
Histone Deacetylase Inhibitor
12%
Breast Cancer
11%
Gene Expression
11%
Small Cytoplasmic RNA
11%
Transfer of Learning
11%
Myeloid-Derived Suppressor Cell
11%
Metastatic Carcinoma
11%
Precursor
11%
Head and Neck Cancer
9%
Patient Experience
9%
Cell Death
9%
Synapsin I
9%
T-Cell Signaling
9%
T Cell Activation
9%
Mass Cytometry
9%
Arginase
9%
Phosphodiesterase V Inhibitor
9%
Antigen Recognition
9%
Cell Maturation
6%
Hyponatremia
6%
RNA Sequencing
6%
Adverse Event
6%
Immunomodulation
6%
Dendritic Cell
6%
Serositis
6%
Cytotoxic Lymphocyte
6%